Inaugural Pharmacogenomics Access and Reimbursement Symposium.
Sara L RogersGeorge P PatrinosChristina MitropoulouChristine M FormeaJ Shawn JonesBenjamin G BrownPublished in: Pharmacogenomics (2021)
The Pharmacogenomics Access & Reimbursement Symposium, a landmark event presented by the Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition, was a 1-day interactive meeting comprised of plenary keynotes from thought leaders across healthcare that focused on value-based strategies to improve patient access to personalized medicine. Stakeholders including patients, healthcare providers, industry, government agencies, payer organizations, health systems and health policy organizations convened to define opportunities to improve patient access to personalized medicine through best practices, successful reimbursement models, high quality economic evaluations and strategic alignment. Session topics included health technology assessment, health economics, health policy and value-based payment models and innovation.
Keyphrases
- healthcare
- public health
- mental health
- health information
- end stage renal disease
- case report
- newly diagnosed
- ejection fraction
- chronic kidney disease
- primary care
- adverse drug
- health promotion
- clinical decision support
- peritoneal dialysis
- transcranial direct current stimulation
- transcription factor
- life cycle
- electronic health record